Journal of Pharmacovigilance and Quality Assurance ISSN: 3108-2343 (Online)

Author: Kushal Sharma

Abstract: Any undesirable and unexpected response to a medication that occurs at levels usually employed in man for prevention, diagnosis, or therapy of illness, or for the change of physiological function, is referred to as an adverse drug reaction (ADR). We would be able to identify and target particular areas for robust pharmacological treatment if we had a better grasp of the frequency and type of ADRs, as well as patient opinions on quality of life. Because ADRs are life-threatening, it is critical to understand the common medicines that cause them, their therapeutic class, demographic data on patients who have experienced ADRs, and the medications they are taking concurrently. ADR specific data, such as the type of reaction, the system impacted, and the likely reasons, will also be very useful in reducing ADRs. To maintain track of newly launched medicines and medical goods, the procedure of identifying and concluding regarding ADRs should be constant and continuing. Furthermore, if possible, strict pharmacological analysis, clinical data, and an in vivo investigation are also necessary. The focus of this article is on the unfavourable response and the techniques for assessing it.

Keywords: Pharmacovigilance program, Adverse drug reaction, Vigflow system, Medications